Maria Alcaide is an Infectious Disease physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 NW 10th Ave
Suite 812. Infectious Diseases
Miami, FL 331361000
Telephone
305-243-5435Registry record last updated 26 Jan 2011.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20242 payments
- Gilead Sciences, Inc.Program year20233 payments
- Gilead Sciences, Inc.Program year20225 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.3%ACE inhibitor24%Lisinopril100%Part D<11 patientsStatin19.3%Rosuvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
41.3%Protease Inhibitor19.3%Symtuza62%Prezcobix38%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor13.3%Tivicay100%Part D<11 patients+ 1 more class in this area
Respiratory
7.3%Leukotriene Receptor Antagonist7.3%Montelukast Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Miami MACS-WIHS Combined Cohort Study Clinical Research Site
University of Miami School of Medicine
FY2026$3,131,404U01HL146203 - A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)
University of Florida
FY2026$683,017R01AI170187 - The CROWN study: Comprehensive Research on Oral and mental health among WomeN
University of Miami School of Medicine
FY2026$640,134R01DE032868
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”